Focus on biomarker discovery, assay validation, and screening strategy evaluation. Works across oncology and cardiology, integrating clinical cohorts, cytology/HPV testing, and interpretable AI through multicenter studies to improve early detection, patient tolerance, and real‑world diagnostic performance.